Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 13, 2020

SELL
$46.37 - $57.58 $648,716 - $805,544
-13,990 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$40.22 - $62.0 $622,967 - $960,318
-15,489 Reduced 52.54%
13,990 $720,000
Q4 2019

Feb 14, 2020

SELL
$57.95 - $66.61 $642,723 - $738,771
-11,091 Reduced 27.34%
29,479 $1.82 Million
Q3 2019

Nov 14, 2019

BUY
$60.08 - $88.17 $494,158 - $725,198
8,225 Added 25.43%
40,570 $2.44 Million
Q2 2019

Aug 14, 2019

BUY
$81.3 - $97.35 $1.11 Million - $1.33 Million
13,693 Added 73.41%
32,345 $2.73 Million
Q1 2019

May 15, 2019

SELL
$69.08 - $105.66 $264,576 - $404,677
-3,830 Reduced 17.04%
18,652 $1.78 Million
Q4 2018

Feb 14, 2019

SELL
$65.41 - $84.65 $507,058 - $656,206
-7,752 Reduced 25.64%
22,482 $1.59 Million
Q3 2018

Nov 14, 2018

BUY
$85.46 - $126.37 $1.29 Million - $1.9 Million
15,062 Added 99.27%
30,234 $2.58 Million
Q2 2018

Aug 14, 2018

SELL
$81.85 - $120.51 $6,302 - $9,279
-77 Reduced 0.5%
15,172 $1.76 Million
Q1 2018

May 15, 2018

BUY
$57.91 - $92.15 $230,076 - $366,111
3,973 Added 35.23%
15,249 $1.23 Million
Q4 2017

Feb 14, 2018

SELL
$45.65 - $59.37 $38,163 - $49,633
-836 Reduced 6.9%
11,276 $662,000
Q3 2017

Nov 14, 2017

BUY
$37.91 - $46.8 $459,165 - $566,841
12,112
12,112 $567,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.